Page last updated: 2024-09-04

atrasentan and Complications of Diabetes Mellitus

atrasentan has been researched along with Complications of Diabetes Mellitus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brunner, F; Kirchengast, M; Saad, Z; Stessel, H; Wölkart, G	1

Other Studies

1 other study(ies) available for atrasentan and Complications of Diabetes Mellitus

Article	Year
Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase. British journal of pharmacology, 2006, Volume: 148, Issue:5 Topics: Acetylcholine; Animals; Antioxidants; Atrasentan; Cardiotonic Agents; Coronary Vessels; Diabetes Complications; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Female; Heart; Heart Rate; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microcirculation; Models, Animal; Muscle Cells; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Norepinephrine; Organ Specificity; Pyrrolidines; Streptozocin	2006

Article

Year

Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase.

British journal of pharmacology, 2006, Volume: 148, Issue:5

Topics: Acetylcholine; Animals; Antioxidants; Atrasentan; Cardiotonic Agents; Coronary Vessels; Diabetes Complications; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Female; Heart; Heart Rate; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microcirculation; Models, Animal; Muscle Cells; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Norepinephrine; Organ Specificity; Pyrrolidines; Streptozocin

2006